Psychedelic Stocks Archives - Page 15 of 61

MondayDec 11, 2023 12:56 pm

AMA Study Shows Safety, Efficacy of Psilocybin in Treating Bipolar Depression

A new clinical study from the American Medical Association (AMA) has indicated that psilocybin-assisted psychotherapy may be safe and effective in the treatment of bipolar II disorder depressive episodes. The nonrandomized controlled study was conducted at Baltimore’s Sheppard Pratt Hospital and involved 15 patients diagnosed with treatment-resistant BDII depression with lengthy depressive episodes. After receiving a single psilocybin dose followed by seven psychotherapy sessions, researchers say study participants “displayed strong and persistent antidepressant effects” with no increase in mood instability of suicidality. Patients with bipolar II disorder (BDII) received a 25-milligram dose of psilocybin and had seven sessions with therapists…

FridayDec 08, 2023 3:55 pm

Researchers Explore Whether Ayahuasca Ceremonies Could Reduce Narcissistic Behavior

A study published in the “Journal of Personality Disorders” has suggested that participation in ayahuasca rituals may reduce narcissistic behavior. The research explored the connection between ayahuasca, a psychedelic brew with a rich history of spiritual, healing and religious use in indigenous Amazonian communities, and narcissistic behavior. Ayahuasca is typically brewed from the Banisteriopsis caapi vine and the leaves of plants containing dimethyltryptamine (DMT) such as Psychotria viridis. The brew triggers a potent hallucinogenic experience once ingested and is usually consumed in ritualistic ceremonies under the guidance of experienced shamans. A typical guided ayahuasca ceremony is meant to put participants…

ThursdayDec 07, 2023 2:44 pm

Psilocybin, LSD Could Be Better Than Opioids in Pain Management

A recent review of scientific psychedelic research has suggested that hallucinogens such as psilocybin (magic mushrooms) and LSD may be more effective at managing pain compared to opioids. The review indicates that classic psychedelics may be effective at mitigating the physical agony caused by pain disorders such as fibromyalgia and injuries. Furthermore, the review noted that the efficacy of these substances can increase over time because they can simultaneously help patients deal with symptoms of mental anguish as well, essentially killing two birds with one stone in a way traditional pain medications such as opioids never could. The past couple…

WednesdayDec 06, 2023 2:46 pm

Psilocybin Reduces Distress in Those Who Suffered Childhood Trauma

A Canadian study published in the “Journal of Psychoactive Drugs” has revealed that psilocybin, the main hallucinogenic agent in magic mushrooms, may reduce psychological distress in individuals with childhood trauma. The researchers found a possible association between magic mushroom use and declines in psychological distress, especially among people with adverse childhood experiences (ACE) after exploring the relationship between psychological distress and psilocybin use. Like several other classic psychedelics, psilocybin has been subject to increased attention in recent years, thanks to anecdotal and scientific claims of its medical efficacy. Previous research efforts have found that psilocybin may be effective at treating…

TuesdayDec 05, 2023 3:47 pm

Why Psychedelics Yield Meaningful Experiences

Psychedelics have been subject to intense public and scientific scrutiny in recent years, thanks to claims of their medical efficacy. Countless studies have now found that psychedelics can induce profound mental changes in patients with hard-to-treat mental disorders such as post-traumatic stress disorder (PTSD) and major depressive disorder, putting psychedelics such as MDMA, LSD and psilocybin on track to becoming approved mental-health treatments. However, long before scientists began running psychedelic clinical trials, regular and even casual psychedelics users knew one thing about this curious class of drugs: psychedelics could induce meaningful and often life-changing experiences in people who took them…

MondayDec 04, 2023 3:12 pm

Psilocybin Clinics Swamped as Out-of-State Patients Flock to Oregon

In 2020, the state of Oregon became the first in the country to legalize psilocybin mushrooms for mental-health treatment through a voter-approved initiative. In January 2023, the state became the first in the country to legalize adult=use psilocybin. In June, Oregon launched its first licensed psilocybin services center. Since then, 17 other licensed centers have launched, with the number of out-of-state visitors recorded thus far being significantly greater than patients from Oregon. Psilocybin is a naturally occurring psychedelic that is produced by more than 200 mushroom species. Numerous studies have shown that this psychedelic compound holds the potential to treat…

FridayDec 01, 2023 12:32 pm

Massachusetts Governor Proposes Bill to Explore Psychedelics Treatments for Veterans

Earlier this month, the governor of Massachusetts filed a measure that would modernize services, increase benefits and promote inclusivity for veterans in the state. Governor Maura Healey filed the resolution, christened the Hero Act, on Veterans Day. The measure would establish a private-public working group to conduct research on the health benefits of psychedelic substances as treatments for veterans suffering from mental health or physical disorders related to their service. It would also expand behavioral-health treatment and provide IVF reimbursement for service members in the LGBTQ community. This isn’t the first psychedelic-focused measure to be introduced in the state, which…

ThursdayNov 30, 2023 1:56 pm

Study Identifies Potential Challenges from Long-Term Psychedelic Use

New research has looked into the lasting challenges people face after using psychedelics such as LSD and psilocybin. The researchers’ motivation lay in the increasing interest in and use of psychedelics for therapeutic purposes as well as personal growth. Numerous studies have shown that psychedelics have the potential to treat conditions such as anxiety, depression and post-traumatic stress disorder. Despite the benefits, however, some individuals may experience challenges following a psychedelic experience. For their research, the investigators used channels such as newsletters, social media, newspaper ads and email lists to recruit more than 600 adults who had experienced challenges that…

TuesdayNov 28, 2023 12:50 pm

Study Suggests Stacking Psychedelic Microdoses with ADHD Medication Could Improve Outcomes

Psychedelics have captured the scientific and mental-health communities’ attention due to extensive claims of their medical efficacy, particularly against hard-to-treat mental disorders. Several studies have connected psychedelics such as psilocybin (magic mushrooms), LSD and MDMA with significant and long-term improvements in mental health. These studies have found that psychedelic therapy can be especially effective when it is paired with traditional psychotherapy and often induces profound and long-term benefits at small doses and with relatively few side effects. Even though the psychedelic field is still in the early research phase, results from clinical studies as well as anecdotal accounts have been…

MondayNov 27, 2023 2:48 pm

Massachusetts Psychedelic Ballot Measure Faces Signature Setback

Efforts to get plant-based psychedelic substances legalized in the state of Massachusetts may have hit a snag after one regulation on gathering signatures was violated. The regulation in question was the printing of the logo of a labor union on ballot sheets, which may have invalidated the whole process. This oversight may prevent the measure from being included on the 2024 ballot. Deborah O’Malley, a spokesperson for the Secretary of State's Office, revealed that the elections’ division found the disqualifying marks and informed the legalization campaign. O’Malley explained that any stray marks or modifications invalidated the whole sheet. The legalization…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks